TCG Crossover Management’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,555,118
| Closed | -$1.66M | – | 39 |
|
|
2024
Q3 | $1.66M | Hold |
1,555,118
| – | – | 0.14% | 34 |
|
|
2024
Q2 | $3.34M | Hold |
1,555,118
| – | – | 0.35% | 29 |
|
|
2024
Q1 | $5.05M | Sell |
1,555,118
-1,123,091
| -42% | -$3.65M | 0.4% | 29 |
|
|
2023
Q4 | $54.9M | Hold |
2,678,209
| – | – | 6.09% | 4 |
|
|
2023
Q3 | $43.1M | Buy |
2,678,209
+1,388,889
| +108% | +$22.3M | 6.34% | 4 |
|
|
2023
Q2 | $11M | Buy |
+1,289,320
| New | +$11M | 1.8% | 16 |
|